New lab expected to begin operations in mid-2009.

PPD reported plans to expand its global central lab services into Singapore in response to growing client demand in Southeast Asia. The lab is expected to begin operations in mid-2009 and will provide biopharmaceutical clients with a comprehensive range of highly customized lab services.

“Southeast Asia is an attractive region for conducting clinical trials, and Singapore is an important biopharmaceutical hub,” said Agostino L. Fede, Ph.D., svp of PPD and head of PPD’s global central labs. “Establishing a direct lab presence in Singapore will enhance our abilities to reduce turnaround time and deliver high-quality specimens and laboratory results at better logistics costs for our clients.”

Previous articleCovance Purchases Equity Stake in Caprion Proteomics
Next articleTalecris Biotherapeutics Inks Second PER.C6 Access Deal with Crucell